BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 21, 2008
View Archived Issues
Pfizer $195M Deal for Encysive Called a 'Good Deal' For Both
Read More
First Working Pancreatic Beta Cells Derived from ESCs
Read More
Bioheart Squeezes Out IPO Window with Meager $5.8M
Read More
Antisense Licenses MS Drug to Teva for $2M Up Front
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Acceleron, Celgene in Potential $1.8B Bone Loss Collaboration
When it came to signing its first biotech collaboration since being founded in 2003, Acceleron Pharma Inc. made sure it was a big one. (BioWorld Today)
Read More